Exscientia PLC
(NAS:EXAI)
$
5.04
-0.16 (-3.08%)
Market Cap: 640.18 Mil
Enterprise Value: 281.73 Mil
PE Ratio: 0
PB Ratio: 1.66
GF Score: 40/100 Exscientia PLC at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023 / 12:10PM GMT
Release Date Price:
$5.56
(-2.28%)
Vikram Purohit
Morgan Stanley, Research Division - Equity Analyst
Let's go ahead and get started. Thanks for joining everyone. This is the fireside chat with Exscientia. My name is Vikram Purohit. I'm one of the biotech analysts with the research team. Before we start our session, I just need to read a brief disclosure statement.
For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative. With that, happy to have with me Andrew Hopkins, CEO, Ben Taylor, CFO of Exscientia. Andrew, Ben, thank you for joining us. Appreciate it.
Andrew L. Hopkins
Exscientia plc - Founder, CEO & Executive Director
You are welcome.
Ben R. Taylor;Vikram Purohit<
Exscientia plc - CFO, Chief Strategy Officer & Executive Director
Thanks for the invite.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot